The presentation on aqueous extract of human placenta at
National Conference on 'Complex Diseases, Novel Therapeutics & Delivery
Challenges' 2014, India by Dr. Piyali Datta Chakraborty, Scientist, Albert
David Ltd, Kolkata opened up before the attendees a lesser known domain for
many. Her presentation was based on 'Placentrex' - the commercial flagship product of Albert David Ltd, is a purified extract of human placenta and is commercially available in the Indian market as injections & gel for topical application. The event took place at Gupta College of Technological Sciences
(GCTS), Asansol, West Bengal, India during January 23-24, 2014.
Excrept from the proceedings:
*Courtesy: Avik Das*, B.Pharm, M.S (USA) Assistant Professor, Department of
Pharmacology, Gupta College of Technological Sciences, Asansol, West Bengal,
India *Correspondence: avik.tox@gmail.com; Tel.:+919748207856
The session of Dr. Piyali Datta Chakraborty, Scientist, Albert
David, Kolkata who spoke of the signature product of their company
'Placentrex', which is a purified extract from the placenta of the newborn.
Placenta which is the biological life line of the baby in the mother's womb
consists of a wide array of biological substances which are known to have
immense therapeutic potential. Besides, this biological treasure house also
serves as a rich source of pleuripotent stem cells which may help in the repair
mechanism of the body. In her talk here, Dr. Chakraborty emphasised specially
on the use of the aqueous extract of placenta in the treatment of non healing
wounds and also advocated its usage in surgical dressings and burn injuries.
She spoke about the different techniques for the commercial production of
'Placentrex' and also discussed shortly about the probable mechanism of action
of the product. She also threw light on the benefits of adding proteolytic
enzymes in proportionate quantity to the extract to gain a synergistic effect
in the process of wound healing. The session indeed opened up before the
audience a new idea which in near future is envisaged to become a torchbearer
in the field of pharmacotherapeutics i.e. pharmacobiotech.
Source:
No comments:
Post a Comment